SciELO - Scientific Electronic Library Online

 
vol.26 issue3Diagnosis and management of primary aldosteronismPrevalence of cardiovascular risk factors in Latin America: a review of the published evidence 2010-2015 author indexsubject indexsearch form
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista mexicana de cardiología

Print version ISSN 0188-2198

Abstract

SANCHEZ-TURCIOS, Reinaldo Alberto. Pheochromocytomas: diagnosis and treatment. Rev. Mex. Cardiol [online]. 2015, vol.26, n.3, pp.118-124. ISSN 0188-2198.

Pheochromocytomas are neoplasms that have their origin in chromaffin cells of the adrenal medulla. 80 to 90% of these are located in one of the adrenal glandules. This pathology is characterized by multiple symptoms that constitute a complex, heterogeneous clinical frame with a high rate of cardiovascular morbidity and mortality. The main secretion is catecholamine metabolites: metanephrine and normetanephrine. Diagnosis is carried out by determining free metanephrines in plasma (not conjugated) and fractioned metanephrines in 24-hour urine collection. Its location through different image procedures is fundamental. Preoperative treatment is initiated with a adrenergic antagonist and by adding, after a week, b adrenergic antagonists. Trans-operative treatment requires a multidisciplinary team of medical experts. This treatment is of vital importance and depends on the size and existence of metastasis. In some cases, adrenal retroperitoneal laparoscopy is preferred. However, an anterior approach is used when the tumor is > 6 cm, but other physicians have considered a 6 cm to 15 cm size. Transoperative follow up is a vital procedure for the patient. Paragangliomas are extra-adrenal ganglia pheochromocytomas.

Keywords : Pheochromocytoma; catecholamine metabolites; surgical treatment.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License